サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1609672

日本のイムノアッセイ市場レポート：技術、製品、用途、最終用途、地域別、2024年～2032年

Japan Immunoassay Market Report by Technology, Product, Application, End Use, and Region 2024-2032

出版日
発行
IMARC
ページ情報
英文 119 Pages
納期
5～7営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
日本のイムノアッセイ市場レポート：技術、製品、用途、最終用途、地域別、2024年～2032年
出版日: 2024年12月05日
発行: IMARC
ページ情報: 英文 119 Pages
納期: 5～7営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

日本のイムノアッセイ市場の市場規模は2023年に18億2,900万米ドルに達しました。今後、IMARC Groupは、市場は2032年までに33億3,640万米ドルに達し、2024年から2032年の間に7.1％の成長率（CAGR）を示すと予測しています。感染症、慢性疾患、がんの有病率の増加と、これらの病気に関連する特定のバイオマーカーの検出に使用されるイムノアッセイなどの診断検査に対する需要の高まりが、主に市場を牽引しています。

本レポートで扱う主な質問

  • 日本のイムノアッセイ市場はこれまでどのように推移し、今後どのように推移していくのか？
  • COVID-19が日本のイムノアッセイ市場に与えた影響は？
  • 日本のイムノアッセイ市場の技術別の内訳は？
  • 日本のイムノアッセイ市場の製品別の内訳は？
  • 日本のイムノアッセイ市場の用途別内訳は？
  • 日本のイムノアッセイ市場の最終用途別の内訳は？
  • 日本のイムノアッセイ市場のバリューチェーンにはどのような段階がありますか？
  • 日本のイムノアッセイの主な促進要因と課題は何か？
  • 日本のイムノアッセイ市場の構造と主要プレーヤーは？
  • 日本のイムノアッセイ市場における競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
  • 市場推定
  • 調査手法

第3章 エグゼクティブサマリー

第4章 日本のイムノアッセイ市場-イントロダクション

  • 概要
  • 市場力学
  • 業界動向
  • 競合情報

第5章 日本のイムノアッセイ市場情勢

  • 過去および現在の市場動向（2018～2023年）
  • 市場予測（2024～2032年）

第6章 日本のイムノアッセイ市場：技術別の内訳

  • 放射イムノアッセイ
  • 酵素イムノアッセイ法
  • 迅速検査
  • その他

第7章 日本のイムノアッセイ市場：製品別の内訳

  • 試薬とキット
  • 分析装置/計測機器
  • ソフトウェアとサービス

第8章 日本のイムノアッセイ市場：用途別の内訳

  • 治療薬モニタリング
  • 腫瘍学
  • 心臓病学
  • 内分泌学
  • 感染症検査
  • 自己免疫疾患
  • その他

第9章 日本のイムノアッセイ市場：最終用途別の内訳

  • 病院
  • 血液銀行
  • 臨床検査室
  • 製薬・バイオテクノロジー企業
  • 学術研究センター
  • その他

第10章 日本のイムノアッセイ市場：競合情勢

  • 概要
  • 市場構造
  • 市場プレーヤーのポジショニング
  • 主要成功戦略
  • 競合ダッシュボード
  • 企業評価象限

第11章 主要企業のプロファイル

第12章 日本のイムノアッセイ市場：業界分析

  • 促進要因・抑制要因・機会
  • ポーターのファイブフォース分析
  • バリューチェーン分析

第13章 付録

目次
Product Code: SR112024A18311

Japan immunoassay market size reached US$ 1,829.0 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 3,336.4 Million by 2032, exhibiting a growth rate (CAGR) of 7.1% during 2024-2032. The increasing prevalence of infectious diseases, chronic conditions, and cancer, coupled with the rising demand for diagnostic tests, including immunoassays, which are used for the detection of specific biomarkers associated with these ailments, is primarily driving the market.

An immunoassay is a powerful laboratory technique used to detect and quantify specific molecules, such as proteins, hormones, or drugs, in biological samples like blood, urine, or tissue. It relies on the principles of the immune system to identify and measure these substances accurately. The process typically involves the use of antibodies, which are proteins that can bind specifically to target molecules called antigens. In an immunoassay, these antibodies are labeled with a detectable marker, such as a fluorescent dye or enzyme, making it possible to track their interactions with the target molecules. Immunoassays come in various forms, including enzyme-linked immunosorbent assays (ELISA), radioimmunoassays (RIA), and fluorescence immunoassays. They offer high sensitivity and specificity, making them valuable tools in medical diagnostics, pharmaceutical research, and various other fields. Immunoassays are widely used for detecting diseases, monitoring treatment responses, and conducting research studies, helping healthcare professionals and scientists better understand and manage a wide range of health conditions.

Japan Immunoassay Market Trends:

The immunoassay market in Japan is poised for significant growth in the coming years, primarily driven by several key factors. Firstly, the increasing prevalence of chronic diseases such as cancer, diabetes, and autoimmune disorders has propelled the demand for immunoassays. These assays play a crucial role in diagnosing and monitoring these conditions, fostering their adoption. Moreover, technological advancements in the field of immunoassays have been instrumental in expanding their applications. Innovations in assay formats, detection methods, and automation have improved the accuracy and sensitivity of immunoassays and also made them more user-friendly and cost-effective, driving their widespread adoption in clinical laboratories. Furthermore, the growing geriatric population in Japan is another significant driver for the immunoassay market. With age, the risk of chronic diseases rises, necessitating regular diagnostic testing, where immunoassays are indispensable. In conclusion, the convergence of factors, including disease prevalence, technological advancements, demographic trends, and the ongoing need for effective diagnostic tools in the face of evolving health challenges, is expected to drive the regional immunoassay market in the coming years.

Japan Immunoassay Market Segmentation:

Technology Insights:

  • Radioimmunoassay
  • Enzyme Immunoassay
  • Rapid Test
  • Others

Product Insights:

  • Reagents and Kits
  • Analyzers/Instruments
  • Software and Services

Application Insights:

  • Therapeutic Drug Monitoring
  • Oncology
  • Cardiology
  • Endocrinology
  • Infectious Disease Testing
  • Autoimmune Diseases
  • Others

End Use Insights:

  • Hospitals
  • Blood Banks
  • Clinical Laboratories
  • Pharmaceutical and Biotech Companies
  • Academic Research Centers
  • Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan immunoassay market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan immunoassay market?
  • What is the breakup of the Japan immunoassay market on the basis of technology?
  • What is the breakup of the Japan immunoassay market on the basis of product?
  • What is the breakup of the Japan immunoassay market on the basis of application?
  • What is the breakup of the Japan immunoassay market on the basis of end use?
  • What are the various stages in the value chain of the Japan immunoassay market?
  • What are the key driving factors and challenges in the Japan immunoassay?
  • What is the structure of the Japan immunoassay market and who are the key players?
  • What is the degree of competition in the Japan immunoassay market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Immunoassay Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Immunoassay Market Landscape

  • 5.1 Historical and Current Market Trends (2018-2023)
  • 5.2 Market Forecast (2024-2032)

6 Japan Immunoassay Market - Breakup by Technology

  • 6.1 Radioimmunoassay
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2018-2023)
    • 6.1.3 Market Forecast (2024-2032)
  • 6.2 Enzyme Immunoassay
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2018-2023)
    • 6.2.3 Market Forecast (2024-2032)
  • 6.3 Rapid Test
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2018-2023)
    • 6.3.3 Market Forecast (2024-2032)
  • 6.4 Others
    • 6.4.1 Historical and Current Market Trends (2018-2023)
    • 6.4.2 Market Forecast (2024-2032)

7 Japan Immunoassay Market - Breakup by Product

  • 7.1 Reagents and Kits
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2018-2023)
    • 7.1.3 Market Forecast (2024-2032)
  • 7.2 Analyzers/Instruments
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2018-2023)
    • 7.2.3 Market Forecast (2024-2032)
  • 7.3 Software and Services
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2018-2023)
    • 7.3.3 Market Forecast (2024-2032)

8 Japan Immunoassay Market - Breakup by Application

  • 8.1 Therapeutic Drug Monitoring
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2018-2023)
    • 8.1.3 Market Forecast (2024-2032)
  • 8.2 Oncology
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2018-2023)
    • 8.2.3 Market Forecast (2024-2032)
  • 8.3 Cardiology
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2018-2023)
    • 8.3.3 Market Forecast (2024-2032)
  • 8.4 Endocrinology
    • 8.4.1 Overview
    • 8.4.2 Historical and Current Market Trends (2018-2023)
    • 8.4.3 Market Forecast (2024-2032)
  • 8.5 Infectious Disease Testing
    • 8.5.1 Overview
    • 8.5.2 Historical and Current Market Trends (2018-2023)
    • 8.5.3 Market Forecast (2024-2032)
  • 8.6 Autoimmune Diseases
    • 8.6.1 Overview
    • 8.6.2 Historical and Current Market Trends (2018-2023)
    • 8.6.3 Market Forecast (2024-2032)
  • 8.7 Others
    • 8.7.1 Historical and Current Market Trends (2018-2023)
    • 8.7.2 Market Forecast (2024-2032)

9 Japan Immunoassay Market - Breakup by End Use

  • 9.1 Hospitals
    • 9.1.1 Overview
    • 9.1.2 Historical and Current Market Trends (2018-2023)
    • 9.1.3 Market Forecast (2024-2032)
  • 9.2 Blood Banks
    • 9.2.1 Overview
    • 9.2.2 Historical and Current Market Trends (2018-2023)
    • 9.2.3 Market Forecast (2024-2032)
  • 9.3 Clinical Laboratories
    • 9.3.1 Overview
    • 9.3.2 Historical and Current Market Trends (2018-2023)
    • 9.3.3 Market Forecast (2024-2032)
  • 9.4 Pharmaceutical and Biotech Companies
    • 9.4.1 Overview
    • 9.4.2 Historical and Current Market Trends (2018-2023)
    • 9.4.3 Market Forecast (2024-2032)
  • 9.5 Academic Research Centers
    • 9.5.1 Overview
    • 9.5.2 Historical and Current Market Trends (2018-2023)
    • 9.5.3 Market Forecast (2024-2032)
  • 9.6 Others
    • 9.6.1 Historical and Current Market Trends (2018-2023)
    • 9.6.2 Market Forecast (2024-2032)

10 Japan Immunoassay Market - Competitive Landscape

  • 10.1 Overview
  • 10.2 Market Structure
  • 10.3 Market Player Positioning
  • 10.4 Top Winning Strategies
  • 10.5 Competitive Dashboard
  • 10.6 Company Evaluation Quadrant

11 Profiles of Key Players

  • 11.1 Company A
    • 11.1.1 Business Overview
    • 11.1.2 Product Portfolio
    • 11.1.3 Business Strategies
    • 11.1.4 SWOT Analysis
    • 11.1.5 Major News and Events
  • 11.2 Company B
    • 11.2.1 Business Overview
    • 11.2.2 Product Portfolio
    • 11.2.3 Business Strategies
    • 11.2.4 SWOT Analysis
    • 11.2.5 Major News and Events
  • 11.3 Company C
    • 11.3.1 Business Overview
    • 11.3.2 Product Portfolio
    • 11.3.3 Business Strategies
    • 11.3.4 SWOT Analysis
    • 11.3.5 Major News and Events
  • 11.4 Company D
    • 11.4.1 Business Overview
    • 11.4.2 Product Portfolio
    • 11.4.3 Business Strategies
    • 11.4.4 SWOT Analysis
    • 11.4.5 Major News and Events
  • 11.5 Company E
    • 11.5.1 Business Overview
    • 11.5.2 Product Portfolio
    • 11.5.3 Business Strategies
    • 11.5.4 SWOT Analysis
    • 11.5.5 Major News and Events

12 Japan Immunoassay Market - Industry Analysis

  • 12.1 Drivers, Restraints, and Opportunities
    • 12.1.1 Overview
    • 12.1.2 Drivers
    • 12.1.3 Restraints
    • 12.1.4 Opportunities
  • 12.2 Porters Five Forces Analysis
    • 12.2.1 Overview
    • 12.2.2 Bargaining Power of Buyers
    • 12.2.3 Bargaining Power of Suppliers
    • 12.2.4 Degree of Competition
    • 12.2.5 Threat of New Entrants
    • 12.2.6 Threat of Substitutes
  • 12.3 Value Chain Analysis

13 Appendix